Victrix Investment Advisors boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 35.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 7,548 shares of the healthcare conglomerate's stock after purchasing an additional 1,973 shares during the quarter. Victrix Investment Advisors' holdings in UnitedHealth Group were worth $2,355,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also added to or reduced their stakes in the stock. Mitsubishi UFJ Asset Management UK Ltd. boosted its stake in UnitedHealth Group by 1,800.0% in the 2nd quarter. Mitsubishi UFJ Asset Management UK Ltd. now owns 3,800 shares of the healthcare conglomerate's stock worth $1,185,000 after purchasing an additional 3,600 shares during the period. Requisite Capital Management LLC purchased a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $670,000. Liberty Capital Management Inc. raised its holdings in shares of UnitedHealth Group by 5.2% in the 2nd quarter. Liberty Capital Management Inc. now owns 14,780 shares of the healthcare conglomerate's stock valued at $4,611,000 after acquiring an additional 726 shares in the last quarter. Wetzel Investment Advisors Inc. raised its holdings in shares of UnitedHealth Group by 14.6% in the 2nd quarter. Wetzel Investment Advisors Inc. now owns 799 shares of the healthcare conglomerate's stock valued at $249,000 after acquiring an additional 102 shares in the last quarter. Finally, Emerald Advisors LLC raised its holdings in shares of UnitedHealth Group by 19.4% in the 2nd quarter. Emerald Advisors LLC now owns 1,089 shares of the healthcare conglomerate's stock valued at $340,000 after acquiring an additional 177 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
UnitedHealth Group Price Performance
Shares of UNH stock opened at $345.11 on Wednesday. The firm has a market cap of $312.56 billion, a P/E ratio of 14.95, a P/E/G ratio of 2.25 and a beta of 0.45. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The business's 50 day moving average price is $303.65 and its 200-day moving average price is $357.64. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.UnitedHealth Group's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were given a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. UnitedHealth Group's payout ratio is currently 38.30%.
Analyst Ratings Changes
Several analysts have weighed in on UNH shares. Truist Financial raised their price target on UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a report on Tuesday, September 9th. Robert W. Baird reissued an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Baird R W cut UnitedHealth Group from a "hold" rating to a "strong sell" rating in a report on Thursday, July 31st. Bank of America raised their price objective on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a report on Monday, August 18th. Finally, JPMorgan Chase & Co. decreased their price objective on UnitedHealth Group from $418.00 to $310.00 and set an "overweight" rating on the stock in a report on Wednesday, August 6th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
View Our Latest Analysis on UNH
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.